Search For "covishield"
WHO welcomes India's emergency use authorisation approval to COVID-19 vacc
Updated : 5 years, 2 months ago IST
Geneva [Switzerland], January 3 (ANI): World Health Organisation (WHO) has welcomed India's decision giving emergency use authorisation to COVID-19 vaccines, informed Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia on Sunday.
Read More
SII CEO says safe, effective COVID-19 vaccine ready for roll-out
Updated : 5 years, 2 months ago IST
New Delhi [India], January 3 (ANI): Covishield, India's first COVID-19 vaccine is approved, safe, effective and ready for roll-out in the coming weeks, said Serum Institute of India Chief Executive Officer Adar Poonawalla on Sunday.
Read More
2020's parting shot: India to roll out COVID-19 vaccine in January
Updated : 5 years, 2 months ago IST
Pune (Maharashtra) [India], December 28 (ANI): In what could be termed as New Year gift, Adar Poonawalla, Chief Executive Officer, Serum Institute of India on Monday said 40-50 million doses of COVID-19 vaccine have already been stockpiled, adding that Covishield rollout is expected in Ja
Read More
Six COVID vaccine candidates in different clinical trial stage in India, t
Updated : 5 years, 3 months ago IST
New Delhi [India], December 8 (ANI): Union Health Secretary Rajesh Bhushan on Tuesday said that there are six COVID-19 vaccine candidates in different clinical trial stages being developed by various manufacturers in India.
Read More
SII CEO thanks PM Modi for support after seeking emergency authorisation o
Updated : 5 years, 3 months ago IST
New Delhi [India], December 7 (ANI): After Serum Institute India (SII) applied for the emergency use authorisation of its coronavirus vaccine "COVISHIELD", its CEO Adar Poonawala expressed gratitude to Prime Minister Narendra Modi and the central government for the support.
Read More
Serum Institute of India seeks emergency use authorisation for its COVID-1
Updated : 5 years, 3 months ago IST
New Delhi [India], December 7 (ANI): The Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for its COVID-19 vaccine "Covishield" in the country.
Read More
Covishield safe, immunogenic; incident with Chennai volunteer no way induc
Updated : 5 years, 3 months ago IST
New Delhi [India], December 1 (ANI): Stressing that the Covishield vaccine is "safe and immunogenic", the Serum Institute of India (SII) on Tuesday said the incident with the Chennai volunteer was in no way induced by the vaccine as "requisite regulatory and ethical processes and guideline"
Read More
No correlation of vaccine trial with Chennai volunteer's side effect claim
Updated : 5 years, 3 months ago IST
New Delhi [India], November 29 (ANI): After a Chennai-based man claimed that he suffered neurological and psychological side effects after taking a shot of COVID-19 vaccine candidate Covishield during the human trial, being conducted by Serum Institute of India's (SII), the Pune-based com
Read More
Centre may purchase 300-400 million Covishield doses by July 2021: Adar Po
Updated : 5 years, 3 months ago IST
New Delhi [India], November 28 (ANI): After Prime Minister Narendra Modi visited the company's pandemic level facility in Pune, Serum Institute of India's (SII), Chief Executive Officer (CEO) Adar Poonawalla on Saturday said that indications suggest that the central government may purchase 3
Read More
Serum Institute of India CEO expresses delight at Covishield vaccine effic
Updated : 5 years, 4 months ago IST
New Delhi [India], November 23 (ANI): Serum Institute of India (SII), CEO, Adar Poonawalla on Monday said that he is delighted to hear that Covidshield, soon to be widely available COVID-19 vaccine, will offer protection up to 90 per cent in one dosage regime and 62 per cent in another.
Read More
COVISHIELD completes enrolment of Phase III clinical trials under ICMR, SI
Updated : 5 years, 4 months ago IST
New Delhi [India], November 12 (ANI): The Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) have announced the completion of enrolment of phase 3 clinical trials for COVISHIELD in India.
Read More
Serum Institute all set to begin phase 3 trials of Covid-19 vaccine
Updated : 5 years, 6 months ago IST
Pune (Maharashtra) [India], September 19 (ANI): Serum Institute of India (SII) is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford University at Sassoon General Hospital in Pune, the hospital administration said on Saturday.
Read More